二甲双胍对头颈部鳞癌FOXP3+与CD8+T细胞浸润的影响
本研究为术前二甲双胍窗口机会试验的回顾性分析,对36例头颈部鳞癌患者(16例HPV阳性、20例HPV阴性)治疗前后肿瘤标本行数字图像分析。
核心结论
- 二甲双胍治疗可能有利地改变头颈部鳞癌的免疫肿瘤微环境,且不依赖HPV状态。
研究设计与样本
- 术前二甲双胍窗口机会试验的回顾性分析,二甲双胍滴定至标准糖尿病剂量2000 mg/天、至少9天(平均13.6天)后手术切除。
- 共分析36例患者(16例HPV阳性、20例HPV阴性)治疗前后手术标本。
- 采用Visiopharm软件数字图像分析定量肿瘤及瘤周间质FOXP3+与CD8+免疫细胞浸润。
主要发现
- 二甲双胍的上述效应不依赖HPV状态。
临床怎么用
- 二甲双胍可能作为头颈部鳞癌免疫治疗联合候选药物,但需进一步前瞻性研究验证。
局限性
- 本研究为回顾性分析,证据级别标注为1b但作者指出更准确描述为非随机对照试验,实际证据水平可能低于1b但高于2a。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Alterations of cellular metabolism have been implicated in immune dysfunction in the tumor microenvironment (TME) of head and neck squamous cell carcinoma (HNSCC). Metformin has recently emerged as a candidate of interest for combination with immunotherapy in HNSCC. This study investigated the effect of metformin on immune cell infiltrates of HNSCC. METHODS: Retrospective analysis of T cell infiltrates in primary tumor specimens from patients enrolled in a clinical window of opportunity trial of presurgical metformin. Metformin was titrated to a standard diabetic dose (2000 mg/day) for a minimum of 9 days (mean 13.6 days) prior to surgical resection. Pre and posttreatment surgical specimens from 36 patients (16 HPV+ , 20 HPV- ) were comparatively analyzed. FOXP3+ and CD8+ immune cell infiltrates in the tumor and peritumoral stroma of pre and posttreatment HNSCC specimens were quantified by digital image analysis using Visiopharm software. RESULTS: Metformin treatment was associated with a 41.4% decrease in FOXP3+ T cells in intratumor regions of interest (P = .004) and a 66.5% increase in stromal CD8+ T cells at the leading edge of the tumor (P = .021) when compared to pretreatment biopsies. This was reflected in increased CD8+ /FOXP3+ cell ratios within the tumor (P < .001) and stromal compartments (P < .001). The effects of metformin occurred independently of HPV status. CONCLUSION: Metformin treatment may favorably alter the immune TME in HNSCC independent of HPV status. LEVEL OF EVIDENCE: 1b. This study is most accurately described as a non-randomized controlled trial and therefore may reflect a level of evidence below 1b but above 2a from the provided "levels of evidence" chart. Laryngoscope, 130:E490-E498, 2020.
引用
- Amin D, Richa T, Mollaee M, et al. Metformin Effects on FOXP3+ and CD8+ T Cell Infiltrates of Head and Neck Squamous Cell Carcinoma. Laryngoscope. 2019. PMID: 31593308. doi:10.1002/lary.28336
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。